PTN

Palatin Technologies, Inc.
NasdaqCMUSDEQUITY Healthcare DELAYED
Last price
9.41
▼ 0.07 (0.74%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
9.48
Day high
9.88
Day low
9.00
Volume
2.76K
Market cap
$16.76M
P/E (TTM)
—
52W range
5.61 – 31.00

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+3.18% +1.2%
1M
-25.91% -27.1%
3M
-8.37% -12.9%
6M
-50.47% -68.7%
YTD
-38.82% -53.1%
1Y
+19.87% +3.5%
3Y
-87.54% -169.8%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

10 more panels on PTN open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
144.43K
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Dec 24, 25
WILLS STEPHEN T
Chief Operating Officer
SELL 565 $9.46K Direct
Dec 9, 25
PRENDERGAST JOHN K. A. PH.D.
Director
STOCK 2.60K $0 Direct
Dec 9, 25
SPANA CARL
Chief Executive Officer
STOCK 885 $0 Direct
Dec 9, 25
WILLS STEPHEN T
Chief Operating Officer
STOCK 770 $0 Direct
Dec 9, 25
DUNTON ALAN WILLIAM
Director
STOCK 2.00K $0 Direct
May 7, 25
DE VEER ROBERT K JR
Director
BUY 100.00K $10.18K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

5 reporting
NameRelationShares heldLatest
DE VEER ROBERT K JR
Director 138.06K Purchase
DUNTON ALAN WILLIAM
Director 14.08K Stock Award(Grant)
PRENDERGAST JOHN K. A. PH.D.
Director 15.10K Stock Award(Grant)
SPANA CARL
Chief Executive Officer 64.70K Stock Award(Grant)
WILLS STEPHEN T
Chief Operating Officer 63.49K Sale

Fundamentals

TTM · reported
Market cap$16.76M
Enterprise value$9.49M
Revenue (TTM)$13.19M
Gross profit$816.16K
EBITDA$-8.61M
Net income$-8.38M
EPS (TTM)$-2.96
Free cash flow$-10.67M
Total cash$7.49M
Total debt$223.68K
Book value / share$5.96
Shares outstanding1.78M
Float1.49M
Short % of float21.34%
Dividend yield0.00%
Beta (5Y)-0.01

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E-5.07
PEG ratio1.62
Price / sales—
Price / book1.58
EV / revenue0.72
EV / EBITDA-1.10
Gross margin6.19%
Operating margin-1469.50%
Profit margin-63.54%
Return on equity-877.53%
Return on assets-91.90%
Debt / equity3.35
Current ratio4.61
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 5 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $0$4.49M$4.85M$1.47M -100.0%
Operating revenue $0$8.88M$12.46M$6.07M -100.0%
Cost of revenue $0$97.64K$418.47K$217.53K -100.0%
Gross profit $0$4.39M$4.44M$1.25M -100.0%
Research & development $14.90M$22.40M$22.63M$21.33M -33.5%
Selling, general & admin $7.81M$12.27M$15.29M$16.51M -36.4%
Total operating expense $22.71M$34.67M$37.92M$37.84M -34.5%
Operating income -$22.71M-$30.28M-$33.49M-$36.59M +25.0%
Net interest income -$15.03K-$17.11K-$20.01K-$29.68K +12.2%
Pre-tax income -$17.31M-$29.74M-$28.71M-$36.20M +41.8%
Tax provision —$0-$4.67M$0 —
Net income -$17.31M-$29.74M-$24.04M-$36.20M +41.8%
Net income to common -$17.31M-$29.74M-$24.04M-$36.20M +41.8%
Basic EPS -32.15-101.16-110.50-189.50 +68.2%
Diluted EPS -32.15-101.16-110.50-189.50 +68.2%
EBIT -$17.29M-$29.72M-$28.69M-$36.17M +41.8%
EBITDA -$17.03M-$29.38M-$28.40M-$36.04M +42.0%
Basic shares 538.35K293.95K217.80K190.88K +83.1%
Diluted shares 538.35K293.95K217.80K190.88K +83.1%

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 -1.13-1.11 +1.3%
Mar 2026 -1.24-0.37 +70.2%
Dec 2025 -1.47-2.86 -94.6%
Sep 2025 —4.26 —
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -1.13 2 $833.33K —
Next quarter -0.42 2 $976.00K +741.1%
Current year -2.99 0 $13.72M —
Next year -1.86 2 $7.33M -14.9%

Analyst targets & ownership

Account required
Mean target$53.50
High target$60.00
Low target$47.50
Implied upside468.54%
Analyst count3
ConsensusSTRONG BUY
Strong buy / Buy1 / 2
Hold0
Sell / Strong sell0 / 0
Held by insiders8.11%
Held by institutions50.11%
Institutions holding30
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
9.51
-1.00% from price
SMA 20
10.34
-8.97% from price
SMA 50
9.94
-5.29% from price
SMA 100
10.89
-13.63% from price
SMA 200
14.95
-37.04% from price
EMA 12
9.69
-2.92% from price
EMA 26
10.08
-6.66% from price
EMA 50
10.38
-9.35% from price
RSI (14)
44.0
Neutral
MACD (12,26,9)
-0.39
Hist -0.15
ATR (14)
0.89
9.46% of price
Realised vol 30D
108.2%
Annualised
Bollinger upper
12.72
20, 2σ
Bollinger lower
7.96
20, 2σ
50 / 200 cross
Death
9.94 vs 14.95
Trend bias
Below 200
-37.04%

Options chain

Account required
Expiry
Spot 9.41
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.10
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
108.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-73.7%
Peak to trough
Max drawdown 5Y
-99.6%
Peak to trough
ATR 14
0.89
9.46% of price
Beta (reported)
-0.01
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
361.21K
Prior 349.50K
Change vs prior
+3.3%
Shorts adding
% of float
21.34%
Heavily shorted
% of shares out
20.30%
Against total outstanding
Days to cover
2.6
Liquid
Float
1.49M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Rating changes

21 on file
DateFirm ActionFromTo
Dec 12, 25 Laidlaw & Co. INITIATED — Buy
Feb 13, 25 HC Wainwright & Co. MAINTAINED Buy Buy
Feb 7, 25 HC Wainwright & Co. MAINTAINED Buy Buy
Dec 19, 24 HC Wainwright & Co. MAINTAINED Buy Buy
Nov 25, 24 HC Wainwright & Co. MAINTAINED Buy Buy
Nov 4, 24 HC Wainwright & Co. MAINTAINED Buy Buy
Oct 31, 24 HC Wainwright & Co. MAINTAINED Buy Buy
Oct 24, 24 HC Wainwright & Co. MAINTAINED Buy Buy
Jun 20, 24 HC Wainwright & Co. MAINTAINED Buy Buy
Jun 12, 24 HC Wainwright & Co. MAINTAINED Buy Buy
May 15, 24 HC Wainwright & Co. MAINTAINED Buy Buy
May 8, 24 HC Wainwright & Co. MAINTAINED Buy Buy

Dividends & splits

Declared · from the issuer
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:50
Split dateAug 12, 2025

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.